![Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes | Neurology Neuroimmunology & Neuroinflammation Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes | Neurology Neuroimmunology & Neuroinflammation](https://www.neurology.org/cms/asset/7c7f9d12-c9f3-41b7-a123-8808b77a3d2d/nxi.8.issue-4.largecover.jpg)
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes | Neurology Neuroimmunology & Neuroinflammation
![Industrialising Drug Delivery - ONdrugDelivery - Issue 89 - August 2018 by ONdrugDelivery Magazine - Issuu Industrialising Drug Delivery - ONdrugDelivery - Issue 89 - August 2018 by ONdrugDelivery Magazine - Issuu](https://image.isu.pub/180810104018-a29290ab33e6725e6052fe95449739be/jpg/page_1_thumb_large.jpg)
Industrialising Drug Delivery - ONdrugDelivery - Issue 89 - August 2018 by ONdrugDelivery Magazine - Issuu
![Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data - The Lancet Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data - The Lancet](https://www.thelancet.com/cms/attachment/dce6c475-5dae-417e-b0c3-822452de7ef0/gr1.jpg)
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data - The Lancet
![Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial - The Lancet Neurology Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial - The Lancet Neurology](https://www.thelancet.com/cms/asset/2d2bc1eb-fb6e-4e5d-b518-85850f080675/gr2.jpg)
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial - The Lancet Neurology
![Pharmaceuticals | Free Full-Text | Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial Pharmaceuticals | Free Full-Text | Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-01079/article_deploy/html/images/pharmaceuticals-16-01079-g001.png)
Pharmaceuticals | Free Full-Text | Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
![JPM | Free Full-Text | Impact of the COVID-19 Pandemic on the Epidemiological Situation of Pulmonary Tuberculosis–Using Natural Language Processing JPM | Free Full-Text | Impact of the COVID-19 Pandemic on the Epidemiological Situation of Pulmonary Tuberculosis–Using Natural Language Processing](https://pub.mdpi-res.com/jpm/jpm-13-01629/article_deploy/html/images/jpm-13-01629-g001-550.jpg?1700626906)
JPM | Free Full-Text | Impact of the COVID-19 Pandemic on the Epidemiological Situation of Pulmonary Tuberculosis–Using Natural Language Processing
![Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2](https://www.thelancet.com/cms/attachment/49184a30-24b4-4e49-9ccb-4bcfbb94581b/gr1.gif)
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2
![Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease | npj Parkinson's Disease Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-023-00573-2/MediaObjects/41531_2023_573_Fig1_HTML.png)
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease | npj Parkinson's Disease
![Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis | Neurology Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis | Neurology](https://www.neurology.org/cms/asset/20f87ba6-9032-416e-b6d8-faa1c0973a6f/wnl.2022.99.issue-16.largecover.jpg)
Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis | Neurology
![The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet](https://www.thelancet.com/cms/attachment/2059ef4d-75ee-40cc-b912-9b0d536a1edc/gr1_lrg.jpg)
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
![Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double‐blind placebo‐controlled clinical trial - Ahlbeck - 2023 - Clinical & Experimental Allergy - Wiley Online Library Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double‐blind placebo‐controlled clinical trial - Ahlbeck - 2023 - Clinical & Experimental Allergy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/59945576-5ccc-43e4-8814-fac9c2832b1c/cea14307-toc-0001-m.jpg)
Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double‐blind placebo‐controlled clinical trial - Ahlbeck - 2023 - Clinical & Experimental Allergy - Wiley Online Library
![Implementation of a primary care asthma management quality improvement programme across 68 general practice sites | npj Primary Care Respiratory Medicine Implementation of a primary care asthma management quality improvement programme across 68 general practice sites | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-023-00341-y/MediaObjects/41533_2023_341_Fig1_HTML.png)
Implementation of a primary care asthma management quality improvement programme across 68 general practice sites | npj Primary Care Respiratory Medicine
![Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations - The Lancet Respiratory Medicine Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/a3a66266-154e-4603-9b0e-a4dfbc04e06a/gr1.jpg)
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations - The Lancet Respiratory Medicine
![Antibiotics | Free Full-Text | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group Antibiotics | Free Full-Text | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group](https://pub.mdpi-res.com/antibiotics/antibiotics-12-00138/article_deploy/html/images/antibiotics-12-00138-g001-550.jpg?1673337115)